Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial costs due to less disease control and more fr...
Saved in:
Main Authors: | Huma Rasheed (Author), Ludwig Höllein (Author), Ulrike Holzgrabe (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020) -
Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
by: Huma Rasheed, et al.
Published: (2019) -
Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020)